Abstract:This study reports the expression, purification, and renaturation of biologically active Transforming Growth Factor-beta(1) (TGF-beta(1)) fusion proteins from Escherichia coli (E. coli). A prokaryotic expression vector was engineered to produce tripartite fusion proteins consisting of (i) a purification tag, (ii) a protease-sensitive linker/collagen binding domain, and (iii) a cDNA sequence encoding the active fragment of human TGF-beta(1). The expressed fusion proteins TGF-B1-F1 and TGF-B1-F2, located in inclusion bodies, were solubilized with 8 M urea and renatured using a glutathione redox-coupled system and protracted dialysis under several experimental conditions. The purification of the recombinant proteins was achieved by binding the His-tag of the fusion proteins on a Ni-NTA metal chelate column The biological activity of the recombinant growth factor was demonstrated by its ability to inhibit mink lung (Mv1Lu) cell proliferation and/or to stimulate proliferation of NIH-3T3 mouse fibroblasts, where purified human platelet TGF-beta(1) served as a positive control. Purified TGF-B1-F1 and TGF-B1-F2 (collagen binding) constructs exhibited anti-proliferative activities comparable to purified platelet TGF-beta(1), but at lower specific activities. Binding of the renatured TGF-B1-F2 fusion protein to collagen was demonstrated by stable binding on a collagen-conjugated Sephadex-G15 column. The high affinity binding was also demonstrated by the binding of H-3-collagen to the TGF-B1-F2 protein immobilized on a Ni-NTA column. The TGF-B1-F2 fusion protein bound to collagen coated surfaces with high affinity but exhibited comparatively lower biological activity than the fusion protein in solution, suggesting a potentially latent configuration. Taken together, these results demonstrate that biologically active TGF-beta(1) fusion proteins can be recovered from transformed bacteria by oxidative refolding; thus, providing a means for its high-yield production, purification, and renaturation from microorganisms. Furthermore, these results support the concept that auxiliary domains may be used to modulate and/or target TGF-beta(1) for specific applications.

Expression and Analysis of the Extracellular Domain of Human Glucocorticoid-Induced Tumor Necrosis Factor Receptor Ligand in Escherichia Coli

[Expression and Identification of Mgitrl by Bac-to-Bac Baculovirus Expression System].

Expression Of Hgitr(Aa27-165) Gene And Preparation, Detection Of Its Polyclonal Antimody

Expression,Purification and Bioactivity Characterization of Extracellular Domain of Murine Osteoprotegerin Ligand

Expression of tumor necrosis factor receptor-immunoglobulin G1 Fc fusion protein in glycoengineered Pichia pastoris

Expression, purification and characterization of human inhibitory receptor TIGIT in E.coli

Prokaryotic Expression and Purification of Mouse GITRL Fusion Protein

Human Glucocorticoid-Induced TNF Receptor Ligand Regulates Its Signaling Activity Through Multiple Oligomerization States

Expression of N-terminal fragment of osteoprotegerin in E. coli and its bioactivity characterization

Cloning,Expression and Bioactivity Analysis of the Active Domain of the Mouse Receptor Activator of NF-κB Ligand

Structural Basis for Ligand-Mediated Mouse GITR Activation

CLONING AND EXPRESSING OF TRANSGLUTAMINASE GENE IN E. COLI

The establishment of an ELISA for measuring GITR and GITRL and its clinical application

[Cloning, Expression and Purification of Human TNF-related Apoptosis-Inducing Ligand in Escherichia Coli].

Expression, purification, and characterization of the active immunoglobulin-like domain of human granulocyte-colony-stimulating factor receptor in Escherichia coli

[Fusion Expression, Purification and Bioassay of IFN-gamma Inducible Protein-10 and Thioredoxin Gene in E. Coli].

Cloning and Expression of Transglutaminase Gene in Escherichia Coli

Expression, Purification, and Characterization of Recombinant Protein GX1-rmhTNFα

Expression, purification and preliminary characterization of glucagon receptor extracellular domain.

Engineering, Expression And Renaturation Of Targeted Tgf-Beta Fusion Proteins

Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for T cell activation